US5354768A
(en)
*
|
1988-07-26 |
1994-10-11 |
Sankyo Company, Limited |
Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents
|
US6277969B1
(en)
*
|
1991-03-18 |
2001-08-21 |
New York University |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
US5356897A
(en)
*
|
1991-09-09 |
1994-10-18 |
Fujisawa Pharmaceutical Co., Ltd. |
3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines
|
GB9303993D0
(en)
*
|
1993-02-26 |
1993-04-14 |
Fujisawa Pharmaceutical Co |
New heterocyclic derivatives
|
TW256831B
(es)
*
|
1993-04-22 |
1995-09-11 |
Senju Pharma Co |
|
BR9406946A
(pt)
*
|
1993-07-06 |
1996-08-06 |
Pfizer |
Tetra-hidro-pirazolpiridinas bicíclicas
|
US6642268B2
(en)
|
1994-09-13 |
2003-11-04 |
G.D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
|
US6262277B1
(en)
|
1994-09-13 |
2001-07-17 |
G.D. Searle And Company |
Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
US6268392B1
(en)
|
1994-09-13 |
2001-07-31 |
G. D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
US6228871B1
(en)
|
1995-07-10 |
2001-05-08 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
AU736854B2
(en)
|
1996-04-25 |
2001-08-02 |
Nissan Chemical Industries Ltd. |
Ethylene derivatives and pesticides containing said derivatives
|
FR2750048B1
(fr)
*
|
1996-06-21 |
1998-08-14 |
Oreal |
Compositions de teinture des fibres keratiniques contenant des derives pyrazolo-(1, 5-a)-pyrimidine, procede de teinture, nouveaux derives pyrazolo-(1, 5-a)-pyrimidine et leur procede de preparation
|
US6417202B1
(en)
*
|
1996-07-11 |
2002-07-09 |
Pfizer Inc. |
Pyridylpyrrole compounds useful as interleukin-and TNF antagonists
|
CA2259583C
(en)
*
|
1996-07-24 |
2009-11-17 |
Du Pont Pharmaceuticals Company |
Azolo triazines and pyrimidines
|
US6191131B1
(en)
|
1997-07-23 |
2001-02-20 |
Dupont Pharmaceuticals Company |
Azolo triazines and pyrimidines
|
US6060478A
(en)
*
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
CZ2005613A3
(cs)
*
|
1996-07-24 |
2017-01-25 |
Bristol-Myers Squibb Pharma Company |
Azolopyrimidiny, jejich použití a farmaceutické kompozice na jejich bázi
|
US7094782B1
(en)
|
1996-07-24 |
2006-08-22 |
Bristol-Myers Squibb Company |
Azolo triazines and pyrimidines
|
US6124289A
(en)
*
|
1996-07-24 |
2000-09-26 |
Dupont Pharmaceuticals Co. |
Azolo triazines and pyrimidines
|
US6313124B1
(en)
|
1997-07-23 |
2001-11-06 |
Dupont Pharmaceuticals Company |
Tetrazine bicyclic compounds
|
KR20010012808A
(ko)
*
|
1997-05-22 |
2001-02-26 |
윌리암스 로저 에이 |
p38 키나아제로서 4-아릴-3(5)-헤테로아릴 치환 피라졸
|
US6979686B1
(en)
|
2001-12-07 |
2005-12-27 |
Pharmacia Corporation |
Substituted pyrazoles as p38 kinase inhibitors
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
US6087496A
(en)
|
1998-05-22 |
2000-07-11 |
G. D. Searle & Co. |
Substituted pyrazoles suitable as p38 kinase inhibitors
|
JP2002502380A
(ja)
|
1997-05-22 |
2002-01-22 |
ジー.ディー.サール アンド カンパニー |
p38キナーゼ阻害剤としてのピラゾール誘導体
|
US6235741B1
(en)
*
|
1997-05-30 |
2001-05-22 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
US6080763A
(en)
*
|
1997-11-03 |
2000-06-27 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds and their use as anti-inflammatory agents
|
EP1473292A1
(en)
*
|
1997-11-03 |
2004-11-03 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
US6380203B1
(en)
*
|
1998-01-14 |
2002-04-30 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
EP1340509A1
(en)
|
1998-12-23 |
2003-09-03 |
G.D. Searle LLC. |
Combinations of cholesteryl ester transfer protein inhibitors and fibric acid derivatives for cardiovascular indications
|
WO2000038723A1
(en)
|
1998-12-23 |
2000-07-06 |
G.D. Searle Llc |
Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
|
AU3103800A
(en)
|
1998-12-23 |
2000-07-31 |
G.D. Searle Llc |
Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acidderivatives for cardiovascular indications
|
WO2000038722A1
(en)
|
1998-12-23 |
2000-07-06 |
G.D. Searle & Co. |
COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS
|
HUP0104793A2
(en)
|
1998-12-23 |
2002-06-29 |
Searle Llc |
Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications
|
ES2200587T3
(es)
|
1998-12-23 |
2004-03-01 |
G.D. Searle Llc |
Combinaciones de inhibidors del transporte de acidos biliares del ileon e inhibidores de la proteina de transferencia de colesteril ester para indicaciones cardiovasculares.
|
MXPA01006470A
(es)
|
1998-12-23 |
2003-06-06 |
Searle Llc |
Combinaciones de inhibidores de transporte de acido biliar ileal y agentes de secuentro de acido biliar para indicaciones cardiovasculares.
|
AU4203500A
(en)
|
1999-04-06 |
2000-10-23 |
Du Pont Pharmaceuticals Company |
Pyrazolopyrimidines as crf antagonists
|
AU4331500A
(en)
|
1999-04-06 |
2000-10-23 |
Du Pont Pharmaceuticals Company |
Pyrazolotriazines as crf antagonists
|
WO2001012621A1
(en)
*
|
1999-08-13 |
2001-02-22 |
Vertex Pharmaceuticals Incorporated |
INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES
|
AU2006203676B2
(en)
*
|
1999-08-13 |
2010-04-22 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-JUN N-Terminal Kinases (JNK) and Other Protein Kinases
|
US6472416B1
(en)
|
1999-08-27 |
2002-10-29 |
Abbott Laboratories |
Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors
|
DK1206474T3
(da)
*
|
1999-08-27 |
2004-10-04 |
Abbott Lab |
Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
|
AU6729900A
(en)
*
|
1999-08-31 |
2001-03-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Organ preservatives
|
WO2001023387A2
(en)
*
|
1999-09-30 |
2001-04-05 |
Neurogen Corporation |
CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES
|
EP1286984A2
(en)
|
2000-03-10 |
2003-03-05 |
Pharmacia Corporation |
Method for the preparation of tetrahydrobenzothiepines
|
US6630476B2
(en)
|
2000-07-07 |
2003-10-07 |
Bristol-Myers Squibb Pharma Company |
Pyrrolo [3,4-d] pyrimidines as corticotropin releasing factor (CRF) antagonists
|
DE10153344A1
(de)
*
|
2001-10-29 |
2003-05-15 |
Gruenenthal Gmbh |
Verwendung von substituierten Pyrazolopyrimidinen als Liganden von Nucleosid-Transport-Proteinen und/oder von Purinorezeptoren
|
UA76461C2
(en)
*
|
2001-05-24 |
2006-08-15 |
Lilly Co Eli |
Pyrrazole derivatives as pharmaceutical agents, use thereof, a pharmaceutical composition on their basis
|
WO2003004497A1
(fr)
*
|
2001-07-05 |
2003-01-16 |
Sumitomo Pharmaceuticals Company, Limited |
Compose heterocyclique
|
WO2003040127A1
(en)
|
2001-11-02 |
2003-05-15 |
G.D. Searle Llc |
Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
|
WO2003053976A1
(en)
*
|
2001-12-20 |
2003-07-03 |
Biovitrum Ab |
PIPAZOLO [1,5-a] PYRIMIDINE DERIVATIVES AS MODULATORS OF PPAR
|
CA2471639A1
(en)
|
2002-01-17 |
2003-07-31 |
Pharmacia Corporation |
Novel alkyl/aryl hydroxy or keto thiepines.
|
ATE365740T1
(de)
*
|
2002-05-10 |
2007-07-15 |
Smithkline Beecham Corp |
Substituierte pyrazolopyrimidine
|
CZ20023575A3
(cs)
*
|
2002-10-25 |
2004-01-14 |
Léčiva, A.S. |
Způsob výroby N-ethyl-N-[3-(3-methyl-pyrazolo[1,5-a]pyrimidin-7-yl)-fenyl]-acetamidu (zaleplonu)
|
EP1567528A1
(en)
*
|
2002-11-21 |
2005-08-31 |
Eli Lilly And Company |
Mixed lineage kinase modulators
|
UA80571C2
(en)
*
|
2002-11-22 |
2007-10-10 |
Lilly Co Eli |
Quinolinyl-pyrrolopyrazoles
|
WO2004110454A1
(ja)
*
|
2003-06-13 |
2004-12-23 |
Ishihara Sangyo Kaisha, Ltd. |
アデノシンA2a受容体アゴニストの投与が必要な疾患を治療又は予防するための組成物
|
DE10332487A1
(de)
*
|
2003-07-16 |
2005-02-10 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Ambroxol für die Behandlung von chronisch nozizeptiven Schmerzen
|
US7511065B2
(en)
|
2003-11-12 |
2009-03-31 |
Eli Lilly And Company |
Mixed lineage kinase modulators
|
WO2006115509A2
(en)
|
2004-06-24 |
2006-11-02 |
Novartis Vaccines And Diagnostics Inc. |
Small molecule immunopotentiators and assays for their detection
|
TW200639163A
(en)
|
2005-02-04 |
2006-11-16 |
Genentech Inc |
RAF inhibitor compounds and methods
|
EP1934185A1
(en)
*
|
2005-08-12 |
2008-06-25 |
Synta Pharmaceuticals Corporation |
Pyrazole compounds that modulate hsp90 activity
|
JP5066516B2
(ja)
*
|
2005-09-01 |
2012-11-07 |
アステラス製薬株式会社 |
疼痛の治療に用いられるピリダジノン誘導体
|
WO2007129195A2
(en)
*
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
US8034834B2
(en)
*
|
2006-05-25 |
2011-10-11 |
Synta Pharmaceuticals Corp. |
Method for treating proliferative disorders with HSP90 inhibitors
|
EP2203453A1
(en)
*
|
2007-09-20 |
2010-07-07 |
Wyeth a Corporation of the State of Delaware |
Pyrazolo[5, 1-c] [1,2,4]triazines, methods for preparation and use thereof
|
WO2009076440A2
(en)
*
|
2007-12-12 |
2009-06-18 |
E.I. Du Pont De Nemours And Company |
Fungicidal bicyclic pyrazoles
|
WO2010096115A1
(en)
*
|
2008-10-29 |
2010-08-26 |
Apath, Llc |
Compounds, compositions and methods for control of hepatitis c viral infections
|
KR101478889B1
(ko)
*
|
2010-02-26 |
2015-01-02 |
미쓰비시 타나베 파마 코퍼레이션 |
피라졸로피리미딘 화합물 및 pde10 억제제로서의 그의 용도
|
US9205086B2
(en)
|
2010-04-19 |
2015-12-08 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitor
|
EP2402339A1
(en)
*
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazolopyridine compounds
|
EP2402345A1
(en)
*
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazole fused bicyclic compounds
|
EP2402344A1
(en)
*
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazole fused bicyclic compounds
|
JP6042896B2
(ja)
|
2011-10-06 |
2016-12-14 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH |
殺菌剤としての複素環ピリ(ミ)ジニルピラゾール
|
WO2013067162A1
(en)
|
2011-11-02 |
2013-05-10 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
|
US20140286902A1
(en)
|
2011-11-02 |
2014-09-25 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitors with platinum-containing agents
|
JP2014533299A
(ja)
|
2011-11-14 |
2014-12-11 |
シンタ ファーマシューティカルズ コーポレーション |
Braf阻害剤とhsp90阻害剤の組合せ療法
|
JO3407B1
(ar)
|
2012-05-31 |
2019-10-20 |
Eisai R&D Man Co Ltd |
مركبات رباعي هيدرو بيرازولو بيريميدين
|
ES2687481T3
(es)
|
2013-03-15 |
2018-10-25 |
Chromocell Corporation |
Moduladores del canal de sodio para el tratamiento del dolor
|
MX2016002794A
(es)
*
|
2013-09-05 |
2016-09-13 |
Genentech Inc |
Compuestos antiproliferativos.
|
SG11201601367QA
(en)
|
2013-09-10 |
2016-03-30 |
Chromocell Corp |
Sodium channel modulators for the treatment of pain and diabetes
|
MX367913B
(es)
*
|
2014-03-27 |
2019-09-11 |
Janssen Pharmaceutica Nv |
Derivados de 4,5,6,7-tetrahidro-pirazolo[1,5-a]pirimidina y 2,3-dihidro-1h-imidazo[1,2-b]pirazol sustituidos como inhibidores de ros1.
|
EA032255B1
(ru)
|
2014-03-27 |
2019-04-30 |
Янссен Фармацевтика Нв |
ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 4,5,6,7-ТЕТРАГИДРОПИРАЗОЛО[1,5-a]ПИРАЗИНА И ПРОИЗВОДНЫЕ 5,6,7,8-ТЕТРАГИДРО-4H-ПИРАЗОЛО[1,5-a][1,4]ДИАЗЕПИНА В КАЧЕСТВЕ ИНГИБИТОРОВ Ros1
|
CN104140427A
(zh)
*
|
2014-07-05 |
2014-11-12 |
湖南华腾制药有限公司 |
一种四氢吡唑并[1,5-a]嘧啶的制备方法
|
EP3193610A4
(en)
*
|
2014-09-09 |
2018-04-04 |
Chromocell Corporation |
Selective nav1.7 inhibitors for the treatment of diabetes
|
KR102384652B1
(ko)
*
|
2015-02-03 |
2022-04-27 |
솔루스첨단소재 주식회사 |
유기 화합물 및 이를 포함하는 유기 전계 발광 소자
|
BR112019003914A2
(pt)
|
2016-08-31 |
2019-05-28 |
Agios Pharmaceuticals Inc |
inibidores de processos metabólicos celulares
|
IL293592A
(en)
|
2019-12-06 |
2022-08-01 |
Vertex Pharma |
Transduced tetrahydrofurans as sodium channel modulators
|
EP4175572A4
(en)
*
|
2020-08-12 |
2024-03-27 |
Spruce Biosciences, Inc. |
METHODS AND COMPOSITIONS FOR TREATING POLYCYSTIC OVARIAN SYNDROME
|
AU2022284886A1
(en)
|
2021-06-04 |
2023-11-30 |
Vertex Pharmaceuticals Incorporated |
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
|